Medibio Ltd: Notice of AGM and Closing Date for Director Nominations
Medibio Ltd: Appendix 4G
Medibio Ltd: Corporate Governance Statement
Medibio Ltd: Phase 2 Trial Commences for SAMDE Study
Medibio Ltd: Trading Halt
Medibio Ltd: June 2023 Quarterly Activities Report and Appendix 4C
Medibio Ltd: Phase 1 Trial Completed for SAMDE Study
Medibio Ltd: Update on Breakthrough Device Designation with US FDA
Medibio Ltd: Change of Director's Interest Notice - David Trimboli
Medibio Ltd: Change of Director's Interest Notice - Chris Ntoumenopoulos
Medibio Ltd: Change in Venue and Time for Extraordinary General Meeting
Medibio Ltd: March 2023 Quarterly Activities Report and Appendix 4C
Medibio Ltd: MEB Executes Bridging Loans with Directors
Medibio Ltd: Initial Director's Interest Notice - Thomas Young
Medibio Ltd: Final Director's Interest Notice
Medibio Ltd: Appendix 3Z
Medibio Ltd: Medibio Lodges Breakthrough Device Designation with FDA
Medibio Ltd: Appendix 3X
Medibio Ltd: Medibio Appoints Non-Executive Director to the Board
Medibio Ltd: Trading Halt
No Data